IGF2 and colorectal cancer: This concept is supported by the finding that, in a mouse model with increased expression of IGF-II, created by crossing mice with an Apc mutation (that predisposes to colorectal cancer) with mice in which the ICR upstream of H19 had been deleted (resulting in biallelic expression of IGF-II).